TRAIL-R1 (human) monoclonal antibody (HS101) (ATTO 647N conjugate)

TRAIL receptor 1, Apo-2, CD261, DR4, Death receptor 4, TNFRSF 10A, TNF-related apoptosis-inducing ligand receptor 1, Tumor necrosis factor receptor superfamily member 10A

Flow Cytometry (1:200) Suggested dilutions/conditions may not be available for all applications.Optimal conditions must be determined individually for each application.

ATTO-fluorescent antibodies show increased photostability, outstanding brightness and intense signals. ATTO dyes are thermally stable, resistant to environmental changes and show no significant isomerization. ATTO 647N shows red fluorescence (λabs (max) : 645nm, λem (max) : 669nm, εmax: 120’000) .